Biotech
-
Business & Markets · Enterprise Phenomic Enters Strategic Collaboration with Boehringer Ingelheim to Discover Novel Targets for Stroma-Rich Cancer Therapies
Insider Brief Phenomic AI has announced a strategic collaboration and licensing agreement with Boehringer Ingelheim to discover targets for stroma-rich cancers, utilizing Phenomic’s scTx® single-cell transcriptomics platform to enhance drug discovery. The partnership focuses… -
Business & Markets · Startups Cradle Raises $24M Series A and Signs Partnerships with Industry Leaders
-
Business & Markets · Startups Vivodyne Announces $38M Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.